Alastair D Hay1,2, Emma Anderson3,2, Sue Ingle2,4, Charles Beck2,5, William Hollingworth4. 1. Centre for Academic Primary Care, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom alastair.hay@bristol.ac.uk. 2. NIHR Health Protection Research Unit in Evaluation of Interventions, University of Bristol, Bristol, United Kingdom. 3. Centre for Child and Adolescent Health, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom. 4. Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom. 5. Field Epidemiology Service, Public Health England, Bristol, United Kingdom.
Abstract
PURPOSE: Describe the duration of symptoms, proportion of parents seeking primary care consultations, and costs for respiratory tract infections (RTIs) of children in the community. METHODS: Community-based, online, prospective inception cohort study. General practitioners from socioeconomically diverse practices posted study invitations to parents of 10,310 children aged ≥3 months and <15 years. RESULTS: One parent of 485 (4.7%) children in 331 families consented, completed baseline data and symptom diaries, and agreed to medical record review. Compared with nonresponders, responding parent's children were younger (aged 4 vs 6 years) and less socioeconomically deprived. Between February and July 2016, 206 parents reported 346 new RTIs in 259 children. Among the 197 first RTIs reported per family, it took 23 days for 90% (95% CI, 85%-94%) of children to recover. Median symptom duration was longer: in children with primary care consultations (9 days) vs those without consultations (6 days, P = 0.06); children aged <3 years (11 days) vs >3 years (7 days, P <.01); and among children with reported lower RTI symptoms (12 days) vs those with only upper RTI symptoms (8 days, P <.001). Sixteen (8.1%; 95% CI, 4.7%-12.8%) of 197 children had primary care consultations at least once (total 19 consultations), and a similar proportion had time off school or nursery. Sixty of 188 (32%; 95% CI, 25%-39%) parents reported paying for medications for their child's illness. CONCLUSIONS: Parents can be advised that RTI symptoms last up to 3 weeks. Policy makers should be aware that parents may seek primary care support in at least 1 in 12 illnesses.
PURPOSE: Describe the duration of symptoms, proportion of parents seeking primary care consultations, and costs for respiratory tract infections (RTIs) of children in the community. METHODS: Community-based, online, prospective inception cohort study. General practitioners from socioeconomically diverse practices posted study invitations to parents of 10,310 children aged ≥3 months and <15 years. RESULTS: One parent of 485 (4.7%) children in 331 families consented, completed baseline data and symptom diaries, and agreed to medical record review. Compared with nonresponders, responding parent's children were younger (aged 4 vs 6 years) and less socioeconomically deprived. Between February and July 2016, 206 parents reported 346 new RTIs in 259 children. Among the 197 first RTIs reported per family, it took 23 days for 90% (95% CI, 85%-94%) of children to recover. Median symptom duration was longer: in children with primary care consultations (9 days) vs those without consultations (6 days, P = 0.06); children aged <3 years (11 days) vs >3 years (7 days, P <.01); and among children with reported lower RTI symptoms (12 days) vs those with only upper RTI symptoms (8 days, P <.001). Sixteen (8.1%; 95% CI, 4.7%-12.8%) of 197 children had primary care consultations at least once (total 19 consultations), and a similar proportion had time off school or nursery. Sixty of 188 (32%; 95% CI, 25%-39%) parents reported paying for medications for their child's illness. CONCLUSIONS: Parents can be advised that RTI symptoms last up to 3 weeks. Policy makers should be aware that parents may seek primary care support in at least 1 in 12 illnesses.
Authors: P Little; J Somerville; I Williamson; G Warner; M Moore; R Wiles; S George; A Smith; R Peveler Journal: Br J Gen Pract Date: 2001-12 Impact factor: 5.386
Authors: Emma C Anderson; Suzanne Ingle; Peter Muir; Charles R Beck; John P Leeming; Joanna Kesten; Christie Cabral; Alastair D Hay Journal: Pilot Feasibility Stud Date: 2018-12-10
Authors: Emma C Anderson; Suzanne Marie Ingle; Peter Muir; Charles Beck; Adam Finn; John Peter Leeming; Christie Cabral; Joanna May Kesten; Alastair D Hay Journal: BMJ Open Date: 2016-08-31 Impact factor: 2.692
Authors: Catherine M Smith; Laura J Shallcross; Peter Dutey-Magni; Anne Conolly; Christopher Fuller; Suzanne Hill; Arnoupe Jhass; Franziska Marcheselli; Susan Michie; Jennifer S Mindell; Matthew J Ridd; Georgios Tsakos; Andrew C Hayward; Ellen B Fragaszy Journal: BMC Infect Dis Date: 2021-01-22 Impact factor: 3.090
Authors: Louise Newbould; Stephen M Campbell; George Edwards; Rebecca L Morris; Gail Hayward; Emma C Hughes; Alastair D Hay Journal: Br J Gen Pract Date: 2021-01-28 Impact factor: 5.386
Authors: Luke J McGeoch; Hannah V Thornton; Peter S Blair; Hannah Christensen; Nicholas L Turner; Peter Muir; Barry Vipond; Niamh M Redmond; Sophie Turnbull; Alastair D Hay Journal: PLoS One Date: 2022-05-12 Impact factor: 3.240
Authors: Susan Langer; Johannes Horn; Cornelia Gottschick; Bianca Klee; Oliver Purschke; Mahrrouz Caputo; Evelyn Dorendorf; Kristin Maria Meyer-Schlinkmann; Heike Raupach-Rosin; André Karch; Nicole Rübsamen; Mustafa Aydogdu; Matthias Buhles; Frank Dressler; Wolfgang Eberl; Franz Edler von Koch; Torsten Frambach; Heiko Franz; Florian Guthmann; Carlos A Guzman; Roland Haase; Gesine Hansen; Valerie Heselich; Johannes Hübner; Hans Georg Koch; Carsten Oberhoff; Peggy Riese; Ralf Schild; Sven Seeger; Michael Tchirikov; Stephanie Trittel; Constantin von Kaisenberg; Rafael Mikolajczyk Journal: Microorganisms Date: 2022-01-05